Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors.

× No keyword cloud information.

15 in total

Review 1. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors: Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal: Circulation Date: 2009-03-26 Impact factor: 29.690

Review 2. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.

Authors: Christopher O Phillips; Amir Kashani; Dennis K Ko; Gary Francis; Harlan M Krumholz
Journal: Arch Intern Med Date: 2007-10-08

Review 3. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Authors: Vasilios G Athyros; Dimitri P Mikhailidis; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis
Journal: Expert Opin Pharmacother Date: 2007-04 Impact factor: 3.889

4. HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Authors: JoAnn Lindenfeld; Nancy M Albert; John P Boehmer; Sean P Collins; Justin A Ezekowitz; Michael M Givertz; Stuart D Katz; Marc Klapholz; Debra K Moser; Joseph G Rogers; Randall C Starling; William G Stevenson; W H Wilson Tang; John R Teerlink; Mary N Walsh
Journal: J Card Fail Date: 2010-06 Impact factor: 5.712

5. The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.

Authors: Finlay A McAlister; Jianguo Zhang; Marcello Tonelli; Scott Klarenbach; Braden J Manns; Brenda R Hemmelgarn
Journal: CMAJ Date: 2011-03-21 Impact factor: 8.262

Review 6. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.

Authors: Rachid Lakhdar; Mouaz H Al-Mallah; David E Lanfear
Journal: J Card Fail Date: 2008-04 Impact factor: 5.712

7. Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.

Authors: Andrea Kuenzli; Heiner C Bucher; Inder Anand; Gregory Arutiunov; Leo C Kum; Robert McKelvie; Rizwan Afzal; Michel White; Alain J Nordmann
Journal: PLoS One Date: 2010-04-01 Impact factor: 3.240

8. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Authors: Johannes F E Mann; Roland E Schmieder; Matthew McQueen; Leanne Dyal; Helmut Schumacher; Janice Pogue; Xingyu Wang; Aldo Maggioni; Andrzej Budaj; Suphachai Chaithiraphan; Kenneth Dickstein; Matyas Keltai; Kaj Metsärinne; Ali Oto; Alexander Parkhomenko; Leopoldo S Piegas; Tage L Svendsen; Koon K Teo; Salim Yusuf
Journal: Lancet Date: 2008-08-16 Impact factor: 79.321

9. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?

Authors: Ann M O'Hare; James S Kaufman; Kenneth E Covinsky; C Seth Landefeld; Lynne V McFarland; Eric B Larson
Journal: Ann Intern Med Date: 2009-05-19 Impact factor: 25.391

10. Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors: Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal: N Engl J Med Date: 2008-03-31 Impact factor: 91.245